Your browser doesn't support javascript.
loading
Risk Factors for the Incidence of and the Mortality due to Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell Transplantation.
Kinzel, Megan; Dowhan, Michelle; Kalra, Amit; Williamson, Tyler S; Dabas, Rosy; Jamani, Kareem; Chaudhry, Ahsan; Shafey, Mona; Jimenez-Zepeda, Victor; Duggan, Peter; Daly, Andrew; Dharmani-Khan, Poonam; Khan, Faisal; Storek, Jan.
Afiliação
  • Kinzel M; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. Electronic address: megan.kinzel1@ucalgary.ca.
  • Dowhan M; Alberta Health Services, Calgary, Alberta, Canada.
  • Kalra A; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Williamson TS; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Dabas R; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Jamani K; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Health Services, Calgary, Alberta, Canada.
  • Chaudhry A; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Health Services, Calgary, Alberta, Canada.
  • Shafey M; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Health Services, Calgary, Alberta, Canada.
  • Jimenez-Zepeda V; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Health Services, Calgary, Alberta, Canada.
  • Duggan P; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Health Services, Calgary, Alberta, Canada.
  • Daly A; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Health Services, Calgary, Alberta, Canada.
  • Dharmani-Khan P; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Health Services, Calgary, Alberta, Canada; Alberta Precision Laboratories, Calgary, Alberta, Canada.
  • Khan F; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Health Services, Calgary, Alberta, Canada; Alberta Precision Laboratories, Calgary, Alberta, Canada.
  • Storek J; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Health Services, Calgary, Alberta, Canada.
Transplant Cell Ther ; 28(1): 53.e1-53.e10, 2022 01.
Article em En | MEDLINE | ID: mdl-34607072
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Infecções por Vírus Epstein-Barr / Transtornos Linfoproliferativos Tipo de estudo: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Infecções por Vírus Epstein-Barr / Transtornos Linfoproliferativos Tipo de estudo: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article